Butterfly Network Research and Development Expenses 2020-2024 | BFLY

Butterfly Network research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Butterfly Network Annual Research and Development Expenses
(Millions of US $)
2024 $38
2023 $56
2022 $88
2021 $74
2020 $50
2019 $49
Butterfly Network Quarterly Research and Development Expenses
(Millions of US $)
2024-12-31 $9
2024-09-30 $9
2024-06-30 $9
2024-03-31 $11
2023-12-31 $11
2023-09-30 $12
2023-06-30 $16
2023-03-31 $17
2022-12-31 $19
2022-09-30 $22
2022-06-30 $23
2022-03-31 $24
2021-12-31 $20
2021-09-30 $22
2021-06-30 $17
2021-03-31 $16
2020-12-31 $13
2020-09-30 $12
2020-06-30 $12
2020-03-31 $13
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.581B $0.082B
Butterfly Network Inc. created handheld, single-probe whole-body ultrasound system, Butterfly iQ. The company through its proprietary Ultrasound-On-Chip(TM) technology, Butterfly Network is paving the way for earlier detection and remote management of health conditions. Butterfly Network Inc., formerly known as Longview Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.281B 54.26
Hims & Hers Health (HIMS) United States $12.358B 128.40
Tempus AI (TEM) United States $10.796B 0.00
Inspire Medical Systems (INSP) United States $4.614B 72.09
IRhythm Technologies (IRTC) United States $4.399B 0.00
Privia Health (PRVA) United States $3.055B 208.83
Enovis (ENOV) United States $2.089B 11.65
Clover Health Investments (CLOV) United States $1.773B 0.00
Schrodinger (SDGR) United States $1.765B 0.00
Phreesia (PHR) United States $1.531B 0.00
Azenta (AZTA) United States $1.296B 60.21
Omnicell (OMCL) United States $1.286B 22.69
10x Genomics (TXG) United States $1.161B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.515B 154.00
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.441B 0.00
TruBridge (TBRG) United States $0.395B 875.67
Claritev (CTEV) United States $0.353B 0.00
Health Catalyst (HCAT) United States $0.315B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.212B 0.00
Nyxoah SA (NYXH) Belgium $0.204B 0.00
EUDA Health Holdings (EUDA) Singapore $0.151B 0.00
Pulmonx (LUNG) United States $0.148B 0.00
American Well (AMWL) United States $0.113B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
CareCloud (CCLD) United States $0.086B 3.27
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
111 (YI) China $0.068B 0.00
P3 Health Partners (PIII) United States $0.061B 0.00
Outset Medical (OM) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00